A Qualitative Study to Assess US Patient Preferences between new Transdermal System and Injectable Anabolic Therapies for Osteoporosis Treatment.

Charlotte BeaudartStuart SilvermanDeborah T GoldSetareh A WilliamsRich WeissMickael Hiligsmann

Published in: Archives of osteoporosis (2022)

This study revealed that efficacy, safety, costs, and convenience are important attributes of osteoporosis treatment for US patients at high risk for fractures when choosing between anabolic therapies, with a high stated preference for sMTS.

Keyphrases

postmenopausal women
end stage renal disease
newly diagnosed
bone mineral density
ejection fraction
peritoneal dialysis
case report
prognostic factors
smoking cessation
tissue engineering